S2N Stock Overview
An investment holding company, engages in the manufacture and sale of edible collagen sausage casing products in Mainland China, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Shenguan Holdings (Group) Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.029 |
| 52 Week High | HK$0.039 |
| 52 Week Low | HK$0.025 |
| Beta | 0.51 |
| 11 Month Change | 3.57% |
| 3 Month Change | 5.45% |
| 1 Year Change | 3.57% |
| 33 Year Change | -40.21% |
| 5 Year Change | 81.25% |
| Change since IPO | -93.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| S2N | DE Food | DE Market | |
|---|---|---|---|
| 7D | 1.8% | -0.6% | -0.02% |
| 1Y | 3.6% | -9.1% | 8.2% |
Return vs Industry: S2N exceeded the German Food industry which returned -10% over the past year.
Return vs Market: S2N underperformed the German Market which returned 7.4% over the past year.
Price Volatility
| S2N volatility | |
|---|---|
| S2N Average Weekly Movement | 17.9% |
| Food Industry Average Movement | 3.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: S2N's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: S2N's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | Yaxian Zhou | www.shenguan.com.hk |
Shenguan Holdings (Group) Limited, an investment holding company, engages in the manufacture and sale of edible collagen sausage casing products in Mainland China, Asia, and internationally. It also manufactures and sells pharmaceutical products and intermediates; collagen food products; skin care products; medical devices; and fine chemicals for human use. The company was founded in 1989 and is headquartered in Causeway Bay, Hong Kong.
Shenguan Holdings (Group) Limited Fundamentals Summary
| S2N fundamental statistics | |
|---|---|
| Market cap | €113.58m |
| Earnings (TTM) | €5.07m |
| Revenue (TTM) | €139.62m |
22.4x
P/E Ratio0.8x
P/S RatioIs S2N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S2N income statement (TTM) | |
|---|---|
| Revenue | CN¥1.05b |
| Cost of Revenue | CN¥849.38m |
| Gross Profit | CN¥204.08m |
| Other Expenses | CN¥165.82m |
| Earnings | CN¥38.26m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.012 |
| Gross Margin | 19.37% |
| Net Profit Margin | 3.63% |
| Debt/Equity Ratio | 14.7% |
How did S2N perform over the long term?
See historical performance and comparison